Results 11 to 20 of about 1,264,036 (325)

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery

Nature Communications, 2022
Reactive oxygen species (ROS) play vital roles in intestinal inflammation. Therefore, eliminating ROS in the inflammatory site by antioxidant enzymes such as catalase and superoxide dismutase may effectively curb inflammatory bowel disease (IBD).
Jun Zhou, Maoyi Li, Qiufang Chen, Xinjie Li, Linfu Chen, Z. Dong, Wenjun Zhu, Yang Yang, Zhuang Liu, Qian Chen   +9 more
semanticscholar   +1 more source

Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease [PDF]

, 2016
OBJECTIVES:Autoimmune liver disease is reported in up to 7.8% of children with inflammatory bowel disease. A distinct inflammatory bowel disease phenotype has been suggested in adults and in small pediatric cohorts.
Alexopoulou, Alvarez, Block, Boonstra, Deneau, Dotson, Faubion, Feldstein, Goyal, Gregorio, Halliday, Hirschfield, Hov, Jose, Jose, Levine, Levine, Liberal, Loftus, Loftus, Lundqvist, Maggiore, Malaty, Mieli-Vergani, Navaneethan, Noble-Jamieson, Olsson, Ordonez, Penna, Rönnblom, Sokol, Zholudev   +31 more
core   +1 more source

Gut microbiota, inflammatory bowel disease and colorectal cancer

World Journal of Gastroenterology, 2022
The gut microbiota is a complex community of microorganisms that inhabit the digestive tracts of humans, living in symbiosis with the host. Dysbiosis, characterized by an imbalance between the beneficial and opportunistic gut microbiota, is associated ...
A. Quaglio, T. G. Grillo, Ellen Cristina Souza de Oliveira, L. D. Di Stasi, L. Sassaki   +4 more
semanticscholar   +1 more source

The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease. [PDF]

, 2018
BACKGROUND: Patients with primary sclerosing cholangitis associated with inflammatory bowel disease (PSC-IBD) have a very high risk of developing colorectal neoplasia.
Bao, X, Brito, H, Moura-Santos, P, Oliveira, A, et al., Palmela, C, Ruiqi, H, Silva, J, Torres, J   +7 more
core   +1 more source

The Gut Microbiota in Inflammatory Bowel Disease

Frontiers in Cellular and Infection Microbiology, 2022
Epidemiological surveys indicate that the incidence of inflammatory bowel disease (IBD) is increasing rapidly with the continuous growth of the economy.
Peng Qiu, T. Ishimoto, Lingfeng Fu, Jun Zhang, Zhenyong Zhang, Yang Liu   +5 more
semanticscholar   +1 more source

Malignancies in Inflammatory Bowel Disease [PDF]

Digestion, 2020
<b><i>Background:</i></b> Inflammatory bowel disease (IBD) is a chronic inflammatory disorder, primarily of, but not restricted to, the gut. Association between IBD and cancer has been clearly established and is uniformly accepted.
Greuter, Thomas, Vavricka, Stephan, König, Alexander O, Beaugerie, Laurent, Scharl, Michael   +4 more
openaire   +6 more sources

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Gut, 2019
Ulcerative colitis and Crohn’s disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal tract, which displays heterogeneity in inflammatory and symptomatic burden between patients and ...
C. Lamb, C. Lamb, N. Kennedy, T. Raine, P. Hendy, P. Hendy, Philip J. Smith, J. Limdi, J. Limdi, B. Hayee, BuʼHussain Hayee, M. Lomer, M. Lomer, G. Parkes, G. Parkes, C. Selinger, C. Selinger, K. Barrett, R. Davies, Cathy Bennett, Stuart Gittens, M. Dunlop, M. Dunlop, O. Faiz, A. Fraser, V. Garrick, Paul D Johnston, M. Parkes, J. Sanderson, J. Sanderson, H. Terry, D. Gaya, D. Gaya, T. Iqbal, T. Iqbal, S. Taylor, S. Taylor, Melissa A. Smith, Melissa A. Smith, M. Brookes, R. Hansen, A. Hawthorne   +41 more
semanticscholar   +1 more source

Serum antibodies in first-degree relatives of patients with IBD: A marker of disease susceptibility? A follow-up pilot-study after 7 years [PDF]

, 2005
Introduction: Various disease-specific serum antibodies were described in patients with inflammatory bowel disease and their yet healthy first-degree relatives.
H.P. Török, J. Glas, H.C. Hollay, R. Gruber, M. Osthoff, L. Tonenchi, C. Brückl, T. Mussack, M. Folwaczny, C. Folwaczny, Glas J, Quinton JF, Ruemmele FM, Cambridge G, Colombel JF, Shanahan F, Hoffman IE, Torok HP, Seibold F, Folwaczny C, Folwaczny C, Folwaczny C, Seibold F, Shanahan F, Folwaczny C, Bansi DS, Klebl FH, Klebl FH, Torok HP, Lombardi G   +29 more
core   +4 more sources

The four epidemiological stages in the global evolution of inflammatory bowel disease

Nature reviews: Gastroenterology & hepatology, 2020
Inflammatory bowel disease (IBD) is a global disease; its evolution can be stratified into four epidemiological stages: Emergence, Acceleration in Incidence, Compounding Prevalence and Prevalence Equilibrium.
G. Kaplan, J. Windsor
semanticscholar   +1 more source

Treatment of Inflammatory Bowel Disease: A Comprehensive Review

Frontiers in Medicine, 2021
Inflammatory bowel disease (IBD), as a global disease, has attracted much research interest. Constant research has led to a better understanding of the disease condition and further promoted its management. We here reviewed the conventional and the novel
Z. Cai, Shu Wang, Jiannan Li
semanticscholar   +1 more source